| Gene symbol | PSCA | Synonyms | PRO232, lncPSCA | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q24.3 | dbXrefs | |
| Description | prostate stem cell antigen | ||||
| Gene symbol | FOLH1 | Synonyms | FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM, PSMA, mGCP | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p11.12 | dbXrefs | |
| Description | folate hydrolase 1 | ||||
| GTO ID | GTC3336 |
| Trial ID | NCT05732948 |
| Disease | Prostate Cancer |
| Altered gene | PSMA|PSCA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PSMA/PSCA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer |
| Year | 2023 |
| Country | China |
| Company sponsor | Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd |
| Other ID(s) | UCTPSMA-PSCA v1.0 |
| Cohort 1 | |||||||||
|
|||||||||